Changes in Sexual Roles and Quality of Life for Gay Men after Prostate Cancer

Challenges for Sexual Health Providers

Tae L. Hart, David Coon, Marc A. Kowalkowski, Karen Zhang, Justin I. Hersom, Heather H. Goltz, Daniela A. Wittmann, David M. Latini

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Introduction: Gay men with prostate cancer (GMPCa) may have differential health-related quality of life (HRQOL) and sexual health outcomes than heterosexual men with prostate cancer (PCa), but existing information is based on clinical experience and small studies. Aims: Our goals were to: (i) describe HRQOL and examine changes in sexual functioning and bother; (ii) explore the psychosocial aspects of sexual health after PCa; and (iii) examine whether there were significant differences on HRQOL and sexual behavior between GMPCa and published norms. Methods: A convenience sample of GMPCa completed validated disease-specific and general measures of HRQOL, ejaculatory function and bother, fear of cancer recurrence, and satisfaction with prostate cancer care. Measures of self-efficacy for PCa management, illness intrusiveness, and disclosure of sexual orientation were also completed. Where possible, scores were compared against published norms. Main Outcome Measures: Main outcome measures were self-reported sexual functioning and bother on the Expanded Prostate Cancer Index. Results: Compared with norms, GMPCa reported significantly worse functioning and more severe bother scores on urinary, bowel, hormonal symptom scales (Ps<0.015-0.0001), worse mental health functioning (P<0.0001), greater fear of cancer recurrence (P<0.0001), and were more dissatisfied with their PCa medical care. However, GMPCa reported better sexual functioning scores (P<0.002) compared with norms. Many of the observed differences met criteria for clinical significance. Physical functioning HRQOL and sexual bother scores were similar to that of published samples. GMPCa tended to be more "out" about their sexual orientation than other samples of gay men. Conclusions: GMPCa reported substantial changes in sexual functioning after PCa treatment. They also reported significantly worse disease-specific and general HRQOL, fear of recurrence, and were less satisfied with their medical care than other published PCa samples. Sexual health providers must have an awareness of the unique functional and HRQOL differences between gay and heterosexual men with PCa.

Original languageEnglish (US)
Pages (from-to)2308-2317
Number of pages10
JournalJournal of Sexual Medicine
Volume11
Issue number9
DOIs
StatePublished - 2014

Fingerprint

Reproductive Health
Prostatic Neoplasms
Quality of Life
Sexual Behavior
Fear
Sexual Minorities
Heterosexuality
Recurrence
Outcome Assessment (Health Care)
Disclosure
Self Efficacy

Keywords

  • Functioning
  • Gay Men
  • Prostate Cancer
  • Quality of Life
  • Symptom

ASJC Scopus subject areas

  • Urology
  • Obstetrics and Gynecology
  • Reproductive Medicine
  • Medicine(all)

Cite this

Changes in Sexual Roles and Quality of Life for Gay Men after Prostate Cancer : Challenges for Sexual Health Providers. / Hart, Tae L.; Coon, David; Kowalkowski, Marc A.; Zhang, Karen; Hersom, Justin I.; Goltz, Heather H.; Wittmann, Daniela A.; Latini, David M.

In: Journal of Sexual Medicine, Vol. 11, No. 9, 2014, p. 2308-2317.

Research output: Contribution to journalArticle

Hart, TL, Coon, D, Kowalkowski, MA, Zhang, K, Hersom, JI, Goltz, HH, Wittmann, DA & Latini, DM 2014, 'Changes in Sexual Roles and Quality of Life for Gay Men after Prostate Cancer: Challenges for Sexual Health Providers', Journal of Sexual Medicine, vol. 11, no. 9, pp. 2308-2317. https://doi.org/10.1111/jsm.12598
Hart, Tae L. ; Coon, David ; Kowalkowski, Marc A. ; Zhang, Karen ; Hersom, Justin I. ; Goltz, Heather H. ; Wittmann, Daniela A. ; Latini, David M. / Changes in Sexual Roles and Quality of Life for Gay Men after Prostate Cancer : Challenges for Sexual Health Providers. In: Journal of Sexual Medicine. 2014 ; Vol. 11, No. 9. pp. 2308-2317.
@article{f37524e0de2b4118b298e149d11ffbc1,
title = "Changes in Sexual Roles and Quality of Life for Gay Men after Prostate Cancer: Challenges for Sexual Health Providers",
abstract = "Introduction: Gay men with prostate cancer (GMPCa) may have differential health-related quality of life (HRQOL) and sexual health outcomes than heterosexual men with prostate cancer (PCa), but existing information is based on clinical experience and small studies. Aims: Our goals were to: (i) describe HRQOL and examine changes in sexual functioning and bother; (ii) explore the psychosocial aspects of sexual health after PCa; and (iii) examine whether there were significant differences on HRQOL and sexual behavior between GMPCa and published norms. Methods: A convenience sample of GMPCa completed validated disease-specific and general measures of HRQOL, ejaculatory function and bother, fear of cancer recurrence, and satisfaction with prostate cancer care. Measures of self-efficacy for PCa management, illness intrusiveness, and disclosure of sexual orientation were also completed. Where possible, scores were compared against published norms. Main Outcome Measures: Main outcome measures were self-reported sexual functioning and bother on the Expanded Prostate Cancer Index. Results: Compared with norms, GMPCa reported significantly worse functioning and more severe bother scores on urinary, bowel, hormonal symptom scales (Ps<0.015-0.0001), worse mental health functioning (P<0.0001), greater fear of cancer recurrence (P<0.0001), and were more dissatisfied with their PCa medical care. However, GMPCa reported better sexual functioning scores (P<0.002) compared with norms. Many of the observed differences met criteria for clinical significance. Physical functioning HRQOL and sexual bother scores were similar to that of published samples. GMPCa tended to be more {"}out{"} about their sexual orientation than other samples of gay men. Conclusions: GMPCa reported substantial changes in sexual functioning after PCa treatment. They also reported significantly worse disease-specific and general HRQOL, fear of recurrence, and were less satisfied with their medical care than other published PCa samples. Sexual health providers must have an awareness of the unique functional and HRQOL differences between gay and heterosexual men with PCa.",
keywords = "Functioning, Gay Men, Prostate Cancer, Quality of Life, Symptom",
author = "Hart, {Tae L.} and David Coon and Kowalkowski, {Marc A.} and Karen Zhang and Hersom, {Justin I.} and Goltz, {Heather H.} and Wittmann, {Daniela A.} and Latini, {David M.}",
year = "2014",
doi = "10.1111/jsm.12598",
language = "English (US)",
volume = "11",
pages = "2308--2317",
journal = "Journal of Sexual Medicine",
issn = "1743-6095",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Changes in Sexual Roles and Quality of Life for Gay Men after Prostate Cancer

T2 - Challenges for Sexual Health Providers

AU - Hart, Tae L.

AU - Coon, David

AU - Kowalkowski, Marc A.

AU - Zhang, Karen

AU - Hersom, Justin I.

AU - Goltz, Heather H.

AU - Wittmann, Daniela A.

AU - Latini, David M.

PY - 2014

Y1 - 2014

N2 - Introduction: Gay men with prostate cancer (GMPCa) may have differential health-related quality of life (HRQOL) and sexual health outcomes than heterosexual men with prostate cancer (PCa), but existing information is based on clinical experience and small studies. Aims: Our goals were to: (i) describe HRQOL and examine changes in sexual functioning and bother; (ii) explore the psychosocial aspects of sexual health after PCa; and (iii) examine whether there were significant differences on HRQOL and sexual behavior between GMPCa and published norms. Methods: A convenience sample of GMPCa completed validated disease-specific and general measures of HRQOL, ejaculatory function and bother, fear of cancer recurrence, and satisfaction with prostate cancer care. Measures of self-efficacy for PCa management, illness intrusiveness, and disclosure of sexual orientation were also completed. Where possible, scores were compared against published norms. Main Outcome Measures: Main outcome measures were self-reported sexual functioning and bother on the Expanded Prostate Cancer Index. Results: Compared with norms, GMPCa reported significantly worse functioning and more severe bother scores on urinary, bowel, hormonal symptom scales (Ps<0.015-0.0001), worse mental health functioning (P<0.0001), greater fear of cancer recurrence (P<0.0001), and were more dissatisfied with their PCa medical care. However, GMPCa reported better sexual functioning scores (P<0.002) compared with norms. Many of the observed differences met criteria for clinical significance. Physical functioning HRQOL and sexual bother scores were similar to that of published samples. GMPCa tended to be more "out" about their sexual orientation than other samples of gay men. Conclusions: GMPCa reported substantial changes in sexual functioning after PCa treatment. They also reported significantly worse disease-specific and general HRQOL, fear of recurrence, and were less satisfied with their medical care than other published PCa samples. Sexual health providers must have an awareness of the unique functional and HRQOL differences between gay and heterosexual men with PCa.

AB - Introduction: Gay men with prostate cancer (GMPCa) may have differential health-related quality of life (HRQOL) and sexual health outcomes than heterosexual men with prostate cancer (PCa), but existing information is based on clinical experience and small studies. Aims: Our goals were to: (i) describe HRQOL and examine changes in sexual functioning and bother; (ii) explore the psychosocial aspects of sexual health after PCa; and (iii) examine whether there were significant differences on HRQOL and sexual behavior between GMPCa and published norms. Methods: A convenience sample of GMPCa completed validated disease-specific and general measures of HRQOL, ejaculatory function and bother, fear of cancer recurrence, and satisfaction with prostate cancer care. Measures of self-efficacy for PCa management, illness intrusiveness, and disclosure of sexual orientation were also completed. Where possible, scores were compared against published norms. Main Outcome Measures: Main outcome measures were self-reported sexual functioning and bother on the Expanded Prostate Cancer Index. Results: Compared with norms, GMPCa reported significantly worse functioning and more severe bother scores on urinary, bowel, hormonal symptom scales (Ps<0.015-0.0001), worse mental health functioning (P<0.0001), greater fear of cancer recurrence (P<0.0001), and were more dissatisfied with their PCa medical care. However, GMPCa reported better sexual functioning scores (P<0.002) compared with norms. Many of the observed differences met criteria for clinical significance. Physical functioning HRQOL and sexual bother scores were similar to that of published samples. GMPCa tended to be more "out" about their sexual orientation than other samples of gay men. Conclusions: GMPCa reported substantial changes in sexual functioning after PCa treatment. They also reported significantly worse disease-specific and general HRQOL, fear of recurrence, and were less satisfied with their medical care than other published PCa samples. Sexual health providers must have an awareness of the unique functional and HRQOL differences between gay and heterosexual men with PCa.

KW - Functioning

KW - Gay Men

KW - Prostate Cancer

KW - Quality of Life

KW - Symptom

UR - http://www.scopus.com/inward/record.url?scp=84908357233&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908357233&partnerID=8YFLogxK

U2 - 10.1111/jsm.12598

DO - 10.1111/jsm.12598

M3 - Article

VL - 11

SP - 2308

EP - 2317

JO - Journal of Sexual Medicine

JF - Journal of Sexual Medicine

SN - 1743-6095

IS - 9

ER -